Celexion is a protein discovery and engineering company based in Cambridge, Massachusetts. The company uses its proprietary SECANT™ platform to display complex proteins on the surface of eukaryotic cells. This platform, combined with state-of-the-art library construction and screening capabilities, allows them to rapidly discover and engineer new proteins for applications in therapeutics, diagnostics, and life science tools.

Flagship Partner Brian Baynes is CEO.

www.celexionbio.com